Ingrid Scott, MD, MPH

    • 14653 Citations
    • 66 h-Index
    1992 …2022
    If you made any changes in Pure, your changes will be visible here soon.

    Fingerprint Dive into the research topics where Ingrid Scott is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

    • 10 Similar Profiles
    Visual Acuity Medicine & Life Sciences
    Endophthalmitis Medicine & Life Sciences
    Macular Edema Medicine & Life Sciences
    Vitrectomy Medicine & Life Sciences
    Retinal Vein Occlusion Medicine & Life Sciences
    Intravitreal Injections Medicine & Life Sciences
    Retinal Detachment Medicine & Life Sciences
    Diabetic Retinopathy Medicine & Life Sciences

    Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Projects 2002 2022

    Retinal Vein
    Retinal Vein Occlusion
    Optical Coherence Tomography
    Visual Acuity
    Clinical Protocols
    Eye Diseases
    Hispanic Americans
    Vision Disorders
    Interviews
    Puerto Rico

    Research Output 1992 2019

    1 Citation (Scopus)

    Intraoperative aberrometry versus preoperative biometry for intraocular lens power selection in short eyes

    Sudhakar, S., Hill, D. C., King, T., Scott, I., Mishra, G., Ernst, B. B. & Pantanelli, S., Jun 1 2019, In : Journal of Cataract and Refractive Surgery. 45, 6, p. 719-724 6 p.

    Research output: Contribution to journalArticle

    Aberrometry
    Biometry
    Intraocular Lenses
    Confidence Intervals
    Eye Axial Length
    1 Citation (Scopus)

    LONG-TERM PHYSICAL STABILITY, STERILITY, AND ANTI-VEGF BIOACTIVITY OF REPACKAGED BEVACIZUMAB IN 2-ML GLASS VIALS

    SCORE2 Investigator Group, Sep 1 2019, In : Retina (Philadelphia, Pa.). 39, 9, p. 1802-1809 8 p.

    Research output: Contribution to journalArticle

    Infertility
    Vascular Endothelial Growth Factor A
    Glass
    Syringes
    Intravitreal Injections

    Month 12 Outcomes after Treatment Change at Month 6 among Poor Responders to Aflibercept or Bevacizumab in Eyes with Macular Edema Secondary to Central or Hemiretinal Vein Occlusion: A Secondary Analysis of the SCORE2 Study

    Ip, M. S., Oden, N. L., Scott, I., Vanveldhuisen, P. C., Blodi, B. A., Ghuman, T. & Baker, C. W., Mar 1 2019, In : JAMA Ophthalmology. 137, 3, p. 281-287 7 p.

    Research output: Contribution to journalArticle

    Macular Edema
    Veins
    Retinal Vein Occlusion
    Visual Acuity
    Therapeutics
    1 Citation (Scopus)

    Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17

    Age-Related Eye Disease Study 2 Research Group, Feb 1 2019, In : Ophthalmology. 126, 2, p. 261-273 13 p.

    Research output: Contribution to journalArticle

    Eye Diseases
    Macular Degeneration
    Natural History
    Confidence Intervals
    Visual Acuity

    Patient-Reported Visual Function Outcomes after Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion: Preplanned Secondary Analysis of a Randomized Clinical Trial

    Scott, I., Vanveldhuisen, P. C., Barton, F., Oden, N. L., Ip, M. S., Blodi, B. A., Worrall, M. & Fish, G. E., Aug 1 2019, In : JAMA Ophthalmology. 137, 8, p. 932-938 7 p.

    Research output: Contribution to journalArticle

    Macular Edema
    Retinal Vein Occlusion
    Vascular Endothelial Growth Factor A
    Retinal Vein
    Veins